The ambient AI that listens to doctor-patient conversations and writes the notes — trusted by 150+ health systems
HQ: Pittsburgh, PA, United States | Founded: 2018 | Employees: ~300 (2026, est.) | Stage: Late Stage VC ($5.3B valuation) | Website: https://www.abridge.com
Abridge was founded in 2018 in Pittsburgh by Dr. Shiv Rao (CEO, a practicing cardiologist who experienced charting burnout firsthand) and Zachary Lipton (a Carnegie Mellon ML professor). Their insight was personal and clinical: the best AI for healthcare would sit at the 'point of conversation' — listening to what doctors and patients actually say, and turning it into the documentation, orders, and follow-ups clinicians need.\n\nThe product records and transcribes doctor-patient conversations on a phone app, then uses specialized clinical models to structure the visit into accurate notes that flow directly into the EHR. Adoption exploded as physician burnout became a national crisis: Abridge reached 150+ health systems, became the first AI scribe officially integrated into Epic (the dominant EHR), and won endorsements from major health systems and strategic backers including CVS Health Ventures and Mayo Clinic.\n\nFinancially, Abridge went from a $200M valuation (October 2023) to $2.75B (February 2025 Series D, $250M) to $5.3B (June 2025 Series E, $300M, led by a16z with Khosla) — with a reported Series E extension (~$316M) reaffirming the $5.3B mark. ARR crossed $100M in May 2025 (up from $60M at end of 2024, with contracted ARR of $117M in Q1 2025) at roughly $2,500 per clinician per year. By 2026 Abridge had expanded from notes into orders, after-visit summaries, and care-intelligence products, cementing its position as the leading independent ambient clinical AI company.
Abridge solved the most painful part of being a doctor: the charting. By recording patient conversations and generating notes automatically, it gives clinicians their evenings back — and that emotional wedge drove the fastest adoption in clinical AI: 150+ health systems, the first official Epic integration for an AI scribe, and ARR from $60M (end 2024) to $100M+ (May 2025) to a valuation of $5.3B within 18 months. The bull case is the doctor-first brand, Epic's seal of approval, and 'care intelligence' expanding from notes to orders and follow-ups; the bear case is competition from Epic's own AI, Nuance/Microsoft, and deep-pocketed rivals — plus the reality that ambient AI economics depend on per-clinician pricing in budget-constrained health systems.
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki